ArticleProceedings of the National Academy of Sciences of the United States of America2020

Concanamycin A counteracts HIV-1 Nef to enhance immune clearance of infected primary cells by cytotoxic T lymphocytes.

Mark M Painter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.